TMED vs. GERM
TMED (T. Rowe Price Health Care ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds. TMED charges 0.44%/yr vs 0.68%/yr for GERM.
Performance
TMED vs. GERM - Performance Comparison
Loading charts...
Returns By Period
TMED
- 1D
- 1.04%
- 1M
- 2.47%
- YTD
- 3.87%
- 6M
- 4.17%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TMED vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 3.87% | 18.92% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| TMED | GERM | Difference | |
|---|---|---|---|
Sharpe Ratio (All Time)Calculated using the full available price history | 1.35 | — | — |
Drawdowns
TMED vs. GERM - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for TMED and GERM.
Loading charts...
Drawdown Indicators
| TMED | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | 0.00% | -11.11% |
Max Drawdown (1Y)Largest decline over 1 year | — | 0.00% | — |
Current DrawdownCurrent decline from peak | -2.75% | 0.00% | -2.75% |
Average DrawdownAverage peak-to-trough decline | -2.59% | 0.00% | -2.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.00% | — |
Volatility
TMED vs. GERM - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.00% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 0.00% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.04% | 0.00% | +18.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.04% | 0.00% | +18.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.04% | 0.00% | +18.04% |
TMED vs. GERM - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is lower than GERM's 0.68% expense ratio.
Dividends
TMED vs. GERM - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.52%, while GERM has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% |
TMED T. Rowe Price Health Care ETF | 0.52% | 0.54% |
Frequently Asked Questions
On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TMED is cheaper with a 0.44% expense ratio, compared with 0.68% for GERM.
TMED has the higher dividend yield at 0.52%, compared with 0.00% for GERM.
They also come from different issuers: T. Rowe Price and Amplify. Their fees differ too: 0.44% for TMED and 0.68% for GERM.
Find the right allocation for TMED and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer